IndraLab

Statements


| 6

reach
"A clinically approved copper chelator, tetrathiomolybdate, inhibits the canonical NLRP3 inflammasome, but not the AIM2, NLRC4, and NLRP1 inflammasomes."

reach
"To further demonstrate that DSF+Cu could inhibit NF-κB activity and NLRP3-secreted IL-1β and CASP1 activation, we performed the experiment using THP-1 and BMDMs, and the results were consistent (Figure S4)."

reach
"A clinically approved copper chelator, tetrathiomolybdate, inhibited the canonical NLRP3 but not the AIM2, NLRC4, and NLRP1 inflammasomes or NF-kappaB-dependent priming."

reach
"In the lungs, for instance, CU has been shown to block the inflammatory NLRP3 pathway, which is responsible for preventing pyroptosis ( Wu et al., 2022 )."

reach
"Further, a copper chelator inhibited the NLRP3 and not the AIM2, NLRC4, and NLRP1 inflammasomes or NF-kappaB-dependent priming 25."

reach
"A study has shown that Cu depletion modulates the canonical NLRP3 pathway [56] , and reports indicate that Cu chelation inhibits Cu-dependent inflammatory cytokines [57] ."